Advances in Janus Kinase Inhibitors for the Treatment of Vitiligo
ZHANG Ruochen
CHEN Xiaojian
ZHANG Xuejun
ZHANG Bo
Abstract：Vitiligo is characterized by a complex pathogenesis,frequent relapse,and resistance to cure.Emerging evidence identifies the Janus kinase-signal transducer and activator of transcription(JAK-STAT)pathway as a tractable therapeutic target.Accordingly,JAK inhibitors have demonstrated promising clinical efficacy in vitiligo and are receiving growing clinical and research attention.This review summarizes recent clinical studies and real-world applications of commonly used JAK inhibitors in the management of vitiligo.
Keywords：VitiligoJanus kinase inhibitorsTreatmentReview
Publication Date：2025-10-10
Online Publishing Date：2025-11-05(First online date of this platform, not the publication date of the document)
Pages：5( 365-369 )